Wednesday, July 8, 2026

biotech · Duchenne Muscular Dystrophy · Duchenne muscular dystrophy · SLDB

Solid Biosciences

Solid Biosciences trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.

500 Rutherford Ave, Third Floor, Boston, Massachusetts 02129, US HQ
2013 Founded
155 Employees
Public company Type
SLDB · NYSE Ticker
Company details
Status
Public
HQ
500 Rutherford Ave, Third Floor, Boston, Massachusetts 02129, US
Founded
2013
Employees
155
Programs
16
Drugs
20
Patents
2
Intelligence · Clinical Trials

Solid Biosciences clinical trials

Registry index of 18 ClinicalTrials.gov studies linked to Solid Biosciences programs — each row shows trial ID, program name, phase, status, and indication.

Solid Biosciences trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Solid Biosciences.

  1. SGT-003-101 — Phase 2

    Clinical update
  2. CWS-2007-HR — Phase 3

    Clinical update
  3. IP — Phase 3

    Clinical update
  4. Erlotinib — Phase 2

    Clinical update
  5. Bevacizumab/Irinotecan — Phase 2

    Clinical update
  6. SGT-003 — Phase 3

    Clinical update
  7. SGT-001 — Phase 2

    Clinical update
  8. dactinomycin — Phase 3

    Clinical update

Trial registry

18 studies